Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

from NYT > Health https://ift.tt/LK1Uc0o
via health&fitness